Although FLCN’s involvement in cell growth control is better understood, it is still not clear how dysregulation of this pathway following FLCN loss could predispose patients to multiple RCC subtypes with different mutational signatures [20]. Here, FLCN is linked to renal cell adenocarcinoma.